Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine in gastric cancer: Where are we and where are we going?

World journal of gastroenterology - 21 Jan 2016

Jácome Alexandre A, Coutinho Anelisa K, Lima Enaldo M, Andrade Aline C, Dos Santos José Sebastião

Abstract excerpt

Despite improvements in adjuvant therapies for gastric cancer in recent years, the disease is characterized by high recurrence rates and a dismal prognosis. The major improvement in the treatment of recurrent or metastatic gastric cancer in recent years has been the incorporation of trastuzumab, a monoclonal antibody that inhibits human epidermal growth factor receptor 2 (HER2) heterodimerization, after the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26811654
DOI: 10.3748/wjg.v22.i3.1160
PMCID: PMC4716027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine in gastric cancer: Where are we and where are we going?PMID 26811654Read ↗

Translating gastric cancer genomics into targeted therapiesSemantic proximity Read ↗

Molecular Profiling of Gastric Cancer: Toward Personalized Cancer MedicineSemantic proximity Read ↗

An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.Semantic proximity Read ↗

Gastric Cancer Genomics: Advances and Future DirectionsSemantic proximity Read ↗

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future PerspectivesSemantic proximity Read ↗

Genomic landscape of gastric cancer: molecular classification and potential targets.Semantic proximity Read ↗

Harnessing technologies to unravel gastric cancer heterogeneity.Semantic proximity Read ↗

Molecular Diagnosis for Personalized Target Therapy in Gastric CancerSemantic proximity Read ↗

The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyondSemantic proximity Read ↗

Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision TherapySemantic proximity Read ↗

Gastric Cancer in the Era of Precision MedicineSemantic proximity Read ↗

Molecular Pathology of Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.